[go: up one dir, main page]

TW200603841A - Dispersible tablets comprising a benzoic acid derivative - Google Patents

Dispersible tablets comprising a benzoic acid derivative

Info

Publication number
TW200603841A
TW200603841A TW094111015A TW94111015A TW200603841A TW 200603841 A TW200603841 A TW 200603841A TW 094111015 A TW094111015 A TW 094111015A TW 94111015 A TW94111015 A TW 94111015A TW 200603841 A TW200603841 A TW 200603841A
Authority
TW
Taiwan
Prior art keywords
benzoic acid
dispersible tablets
acid derivative
weight
dispersible
Prior art date
Application number
TW094111015A
Other languages
English (en)
Inventor
Catherine Beauchamp
Jean-Pierre Cassiere
Florian Battung
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TW200603841A publication Critical patent/TW200603841A/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW094111015A 2004-04-08 2005-04-07 Dispersible tablets comprising a benzoic acid derivative TW200603841A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0408078.4A GB0408078D0 (en) 2004-04-08 2004-04-08 Organic compounds

Publications (1)

Publication Number Publication Date
TW200603841A true TW200603841A (en) 2006-02-01

Family

ID=32320645

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094111015A TW200603841A (en) 2004-04-08 2005-04-07 Dispersible tablets comprising a benzoic acid derivative

Country Status (14)

Country Link
US (1) US20080312302A1 (zh)
EP (1) EP1734924A1 (zh)
JP (1) JP2007532509A (zh)
CN (1) CN1997348A (zh)
AR (1) AR048864A1 (zh)
AU (2) AU2005230402A1 (zh)
BR (1) BRPI0509645A (zh)
CA (1) CA2559739A1 (zh)
GB (1) GB0408078D0 (zh)
PA (1) PA8629501A1 (zh)
PE (1) PE20060717A1 (zh)
RU (1) RU2396954C2 (zh)
TW (1) TW200603841A (zh)
WO (1) WO2005097062A1 (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007051773A1 (en) * 2005-11-01 2007-05-10 Novartis Ag Method of scintigraphy
MX2008014292A (es) 2006-05-09 2008-11-18 Novartis Ag Combinacion que comprende un quelante de hierro y un agente anti-neoplastico, y uso de la misma.
DK2026801T3 (da) * 2006-05-23 2014-01-27 Novartis Ag Deferasirox til behandling af arvelig hæmochromatose
KR20150046369A (ko) 2006-11-29 2015-04-29 노파르티스 아게 데페라시록스 (icl670a)의 다형체 형태
JPWO2010032489A1 (ja) 2008-09-22 2012-02-09 国立大学法人旭川医科大学 鉄キレート剤及びその製造方法、並びに鉄イオンの定量・捕捉方法
EA201390079A1 (ru) * 2010-07-08 2013-09-30 Рациофарм Гмбх Пероральная лекарственная форма деферазирокса
CA2812505A1 (en) 2010-10-01 2012-04-05 Cipla Limited Pharmaceutical composition
WO2012096183A1 (ja) 2011-01-14 2012-07-19 株式会社ダステック 高分子鉄キレート剤
WO2014072673A1 (en) 2012-11-12 2014-05-15 Cipla Limited Fixed dose pharmaceutical composition comprising deferasirox and deferipone
KR20170045391A (ko) * 2013-03-08 2017-04-26 노파르티스 아게 데페라시록스의 경구 제제
MX2015015553A (es) 2013-05-10 2016-06-17 Cipla Ltd Composicion farmceutica de dosis baja.
ES2734675T3 (es) 2014-05-20 2019-12-11 Sanovel Ilac Sanayi Ve Ticaret As Formulación de comprimido dispersable en agua que contiene deferasirox
EP2987482A1 (en) 2014-08-22 2016-02-24 Santa Farma Ilaç Sanayi A.S. Soluble and dispersible pharamaceutical deferasirox formulation
WO2016167729A1 (en) 2015-04-16 2016-10-20 Öğün Yusuf Toktamiş Dispersible tablets comprising deferasirox
WO2018007956A1 (en) * 2016-07-05 2018-01-11 Jubilant Generics Limited Immediate release pharmaceutical composition of iron chelating agents
EP3518904A1 (en) 2016-09-30 2019-08-07 Synthon B.V. Pharmaceutical composition comprising deferasirox
CZ2017255A3 (cs) 2017-05-04 2018-11-14 Zentiva, K.S. Filmem potažené tablety Deferasiroxu
WO2018208242A1 (en) 2017-05-10 2018-11-15 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Formulation of deferasirox tablet for oral suspension composition with better processability
EP3675832A1 (en) 2017-09-01 2020-07-08 Jordan Sweden Medical and Sterilization Company Fast self dispersible dosage forms of deferasirox
TR201722910A2 (tr) 2017-12-29 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Deferasi̇roks i̇çeren suda dağilabi̇len tablet formülasyonlari

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
DE4412117A1 (de) * 1994-04-08 1995-10-12 Fette Wilhelm Gmbh Verfahren und Vorrichtung zum Aufbringen von pulverförmigem Schmier- oder Trennmittel auf die Preßwerkzeuge in Tablettiermaschinen
MY129541A (en) * 1996-06-25 2007-04-30 Novartis Ag Substituded 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
JP2002505269A (ja) * 1998-03-06 2002-02-19 エウランド インターナショナル ソシエタ ペル アチオニ 急速崩壊錠剤
US6284270B1 (en) * 1999-08-04 2001-09-04 Drugtech Corporation Means for creating a mass having structural integrity
US7961712B2 (en) * 2000-05-08 2011-06-14 Broadcom Corporation System and method for supporting multiple voice channels
RU2003129506A (ru) * 2001-03-06 2005-03-10 Киова Хакко Когио Ко., Лтд. (Jp) Быстрораспадающаяся во рту таблетка
GB0223978D0 (en) * 2002-10-15 2002-11-20 Novartis Ag Organic compound

Also Published As

Publication number Publication date
RU2006139000A (ru) 2008-05-20
WO2005097062A1 (en) 2005-10-20
BRPI0509645A (pt) 2007-09-18
US20080312302A1 (en) 2008-12-18
AU2005230402A1 (en) 2005-10-20
CN1997348A (zh) 2007-07-11
AU2009201696A1 (en) 2009-05-21
EP1734924A1 (en) 2006-12-27
PA8629501A1 (es) 2005-11-25
CA2559739A1 (en) 2005-10-20
GB0408078D0 (en) 2004-05-12
JP2007532509A (ja) 2007-11-15
PE20060717A1 (es) 2006-08-02
AR048864A1 (es) 2006-06-07
RU2396954C2 (ru) 2010-08-20

Similar Documents

Publication Publication Date Title
MY140999A (en) Dispersible tablets comprising a benzoic acid derivative
TW200603841A (en) Dispersible tablets comprising a benzoic acid derivative
GEP20094627B (en) High drug load tablet
TNSN08173A1 (en) Dispersible tablets comprising deferasirox
MY148773A (en) Galenic formulations of organic compounds
WO2003063864A3 (fr) Composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
NO20062004L (no) Forlenget frigjoring farmasoytiske blandinger omfattene aplindor og derivater derav
NZ600231A (en) Pharmaceutical compositions comprising sigma receptor ligands
WO2008020040A3 (en) 2,5-dihydroxybenzene compounds for the treatment of fibrosis
WO2008023016A3 (en) Galenic formulations of aliskiren
TN2009000487A1 (en) Triazol compounds for treating biofilm formation
WO2007014124A3 (en) High drug load formulations and dosage forms
WO2010038091A3 (en) Compositions comrrising amlodipine and bisoprolol
MX2009007038A (es) Derivados de mononitrato de isosorbida para el tratamiento de trastornos intestinales.
WO2005070427A8 (en) Compounds for the sustained reduction of body weight
WO2008065144A3 (en) Galenic formulations of organic compounds
TN2010000120A1 (en) Galenical formulations of organic compounds
TW200640472A (en) Solid pharmaceutical composition comprising telithromycin
WO2009047904A1 (ja) ウラシル誘導体を有効成分とする炎症性腸疾患治療薬
WO2007052167A3 (en) Stable composition for a pharmaceutical formulation containing olanzapine
TW200607498A (en) Agents for prevention or treatment of diseases associated with endothelial hyperproliferation
WO2007006738A3 (en) Pharmaceutical composition comprising 2 , 3-disubstituted tropanes for the treatment of disorders of sexual desire
TH118221A (th) สูตรผสมกาเลนนิคัลของสารประกอบอินทรีย์